Scholars@Duke

T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy

Conferences
Rotstein, T; Brown, M; McCutcheon, S; Gersbach, CA
Published in: MOLECULAR THERAPY
April 22, 2024
Link to item

Duke Scholars

Charles Gersbach
Author Charles Gersbach Biomedical Engineering
Altmetric Attention Stats
Dimensions Citation Stats

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2024

Volume

32

Issue

4

Start / End Page

101 / 101

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rotstein, T., Brown, M., McCutcheon, S., & Gersbach, C. A. (2024). T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy. In MOLECULAR THERAPY (Vol. 32, pp. 101–101).
Rotstein, Tomer, Mike Brown, Sean McCutcheon, and Charles A. Gersbach. “T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy.” In MOLECULAR THERAPY, 32:101–101, 2024.
Rotstein T, Brown M, McCutcheon S, Gersbach CA. T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy. In: MOLECULAR THERAPY. 2024. p. 101–101.
Rotstein, Tomer, et al. “T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy.” MOLECULAR THERAPY, vol. 32, no. 4, 2024, pp. 101–101.
Rotstein T, Brown M, McCutcheon S, Gersbach CA. T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy. MOLECULAR THERAPY. 2024. p. 101–101.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2024

Volume

32

Issue

4

Start / End Page

101 / 101

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics